Jonathan Jay Mazelsky - 14 Feb 2022 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
President & CEO, Director
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Jonathan Jay Mazelsky
Issuer symbol
IDXX
Transactions as of
14 Feb 2022
Net transactions value
-$719,369
Form type
4
Filing time
16 Feb 2022, 18:24:40 UTC
Previous filing
17 Aug 2021
Next filing
07 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $0 +459 +0.93% $0.000000 49,905 14 Feb 2022 Direct F1
transaction IDXX Common Stock Options Exercise $0 +505 +1% $0.000000 50,410 14 Feb 2022 Direct
transaction IDXX Common Stock Options Exercise $0 +435 +0.86% $0.000000 50,845 14 Feb 2022 Direct
transaction IDXX Common Stock Options Exercise $0 +974 +1.9% $0.000000 51,819 14 Feb 2022 Direct
transaction IDXX Common Stock Options Exercise $0 +690 +1.3% $0.000000 52,509 14 Feb 2022 Direct
transaction IDXX Common Stock Tax liability $719,369 -1,423 -2.7% $505.53 51,086 14 Feb 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Non-Qualified Stock Option (right-to-buy) Award +22,366 22,366 14 Feb 2022 Common Stock 22,366 $505.53 Direct F2, F11
transaction IDXX Premium Non-Qualified Stock Option (right-to-buy) Award +12,557 12,557 14 Feb 2022 Common Stock 12,557 $556.08 Direct F3, F11
transaction IDXX Incentive Stock Option (right-to-buy) Award +197 197 14 Feb 2022 Common Stock 197 $505.53 Direct F4, F11
transaction IDXX Restricted Stock Unit Award +3,833 +40% 13,438 14 Feb 2022 Common Stock 3,833 Direct F5, F11
transaction IDXX Restricted Stock Unit Options Exercise -459 -3.4% 12,979 14 Feb 2022 Common Stock 459 Direct F6, F11
transaction IDXX Restricted Stock Unit Options Exercise -505 -3.9% 12,474 14 Feb 2022 Common Stock 505 Direct F7, F11
transaction IDXX Restricted Stock Unit Options Exercise -435 -3.5% 12,039 14 Feb 2022 Common Stock 435 Direct F8, F11
transaction IDXX Restricted Stock Unit Options Exercise -974 -8.1% 11,065 14 Feb 2022 Common Stock 974 Direct F9, F11
transaction IDXX Restricted Stock Unit Options Exercise -690 -6.2% 10,375 14 Feb 2022 Common Stock 690 Direct F10, F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes a total of 19 shares purchased under the Issuer's Employee Stock Purchase Plan on September 30, 2021 and December 31, 2021.
F2 Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2023.
F3 Grant of option at a 110% premium to the closing price of Issuer common stock on the NASDAQ Global Select Market on February 14, 2022 to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2023.
F4 Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on the fourth anniversary of the date of grant.
F5 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023.
F6 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2018.
F7 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2019.
F8 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020.
F9 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021.
F10 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022.
F11 Not applicable.